Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
批准号:
10455479
负责人:
KHALID MATROUGUI
金额:
$37.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-06-30
关键词:
AddressAdverse eventAngiotensinsAnti-Inflammatory AgentsApoptosisBiologicalBlood VesselsCardiovascular DiseasesCardiovascular systemCell CommunicationCell CountCell DeathCell membraneCell physiologyCellsChimera organismClinicalClipComplicationCytokine SignalingDataDendritic CellsDendritic cell activationDevelopmentEndoplasmic ReticulumEndothelial CellsFemaleFibrosisGenerationsGenotypeGoalsHypertensionIL2RA geneImmuneImmune systemInflammationInflammatoryInfusion proceduresInterferon Type IIInterleukin-1 betaKidneyKnockout MiceMediator of activation proteinMenopauseMissionModelingMolecularMorbidity - disease rateMusNational Heart, Lung, and Blood InstituteOutcomeOvariectomyPathologic ProcessesPathologyPatientsPreventiveProteinsPublic HealthRegulatory T-LymphocyteReportingResearch PrioritySTIM1 geneShipsSignal TransductionStrategic PlanningStructureT-LymphocyteTailTestingTherapeuticTranslational ResearchTranslationsVascular DiseasesVascular EndotheliumVascular Systembaseblood pressure elevationcalcificationcardiovascular risk factorclinically significantcytokinedesignendoplasmic reticulum stressendothelial dysfunctiongene therapyhigh riskhypertensiveimprovedmalemortalitymouse modelmultidisciplinarynovel therapeuticsoverexpressionpreventtherapy resistant
中文摘要
摘要-高血压诱导的血管病理学的中枢机制,一个公共的
健康危机,仍然未知。高血压患者的不良事件发生率仍然很高
这些治疗和2/3的高血压患者仍然耐药这些治疗。因此,在本发明中,
关键的未满足的需求是确定基于机制的可治疗靶点以挽救血管功能,
高血压的结构。试验数据显示,将健康的Treg转移到小鼠体内,
血管紧张素II(Ang II)输注诱导的高血压患者,
功能和结构。我们发现,在高分化的乳腺癌中,基质相互作用分子1(STIM 1)的表达增加。
Treg可能通过Nox 2和内质网(ER)应激导致Treg凋亡-
依赖机制。STIM 1在Treg细胞中的过表达可导致Treg细胞凋亡。的
高血压小鼠中树突状细胞的耗竭改善了动脉功能并减少了动脉纤维化,
通过减少树突状细胞释放的INFγ和IL-1β以及抑制ER
内皮细胞的压力。中心假设是,STIM 1在Treg细胞中的过表达,通过
ROS和ER应激机制导致Treg细胞凋亡并减少IL-10的释放,
树突状细胞活性导致促炎细胞因子释放(INFγ和IL-1β)增加,
抗炎性IL-10释放的减少导致内皮细胞中ER应激的诱导,
血管病理学为了推进转化科学,我们将在两肾一肾中测试这一假设-
夹子(2K 1C)高血压小鼠血管紧张素II依赖性。具体目标#1:确定在建立
高血压时,Treg细胞中STIM 1表达增加,导致Treg细胞凋亡,IL-10表达减少,
释放和血管病理学。因此,破坏Treg细胞中的STIM 1表达将恢复Treg细胞
数量,IL-10水平,并改善血管内皮功能,减少纤维化和钙化,
确诊高血压具体目标#2:描述由于以下原因导致的IL-10释放减少:
Treg中的细胞凋亡,增加树突状细胞释放IFNγ和IL-1β的活性,并抑制IL-10的释放,
通过诱导内皮细胞中的ER应激机制引起血管病理学,因此
去除树突状细胞或操纵内皮细胞中的ER应激可以改善血管内皮细胞的功能。
在2K 1C诱导的高血压中发挥作用并减少纤维化和钙化。这些研究
是《国家HLBI》使命的核心,涉及《国家HLBI》中概述的所有目标和多项战略
战略计划。这些研究将解决1)需要进一步阐明生物学机制,
免疫细胞的贡献的病理过程,2)免疫细胞之间的相互作用,
系统和血管系统作为优先研究课题,3)推进转化科学,
我们将在2K 1C小鼠模型中检验这一假设。
英文摘要
ABSTRACT — The central mechanisms involved in hypertension-induced vascular pathology, a public
health crisis, remain unknown. There is still a significant rate of adverse events in hypertensive patients
prescribed these therapeutic and 2/3 of hypertensive patients are still resistant to these therapies. Thus,
the critical unmet need is to identify mechanism based-treatable targets to rescue vascular function and
structure in established hypertension. The pilot data showed that transferring healthy Treg into a mouse
with established hypertension-induced by angiotensin II (Ang II) infusion improved vascular endothelial
function and structure. We showed an increase in stromal interaction molecule 1 (STIM1) expression in
Treg that could be responsible for Treg apoptosis by Nox2 and endoplasmic reticulum (ER) stress-
dependent mechanisms. The overexpression of STIM1 in Treg cell caused Treg cell apoptosis. The
depletion of dendritic cells in hypertensive mice improved arterial function and reduced arterial fibrosis and
calcification through a reduction in INFγ and IL-1β release from dendritic cells and the inhibition of the ER
stress in the endothelial cells. The central hypothesis is that STIM1 overexpression in Treg cells, through
ROS and ER stress mechanism, cause Treg cells apoptosis and decrease IL-10 release, which increases
dendritic cell activity leading to an increase in pro-inflammatory cytokines release (INFγ and IL-1β) and a
decrease in anti-inflammatory IL-10 release causing the induction of the ER stress in endothelial cells and
vascular pathology. To advance the Translational Sciences, we will test the hypothesis in two-kidney one-
clip (2K1C) hypertensive mice Ang II-dependent. Specific Aim #1: To determine that in established
hypertension, STIM1 expression is increased in Treg cells causing Treg cells apoptosis, a decrease in IL-10
release, and vascular pathology. Thus disrupting STIM1 expression in Treg cells would restore Treg cells
number, IL-10 levels, and improve vascular endothelial function and reduce fibrosis and calcification in
established hypertension. Specific Aim #2: To delineate that the decrease in IL-10 release, because of
apoptosis in Treg, increases dendritic cells activity to release IFNγ and IL-1β and blunt IL-10 release, which
causes vascular pathology via the induction of the ER stress mechanism in endothelial cells, and therefore
depleting dendritic cells or manipulating the ER stress in endothelial cell improve vascular endothelial
function and reduce fibrosis and calcification in established hypertension-induced by 2K1C. These studies
are central to the mission of the NHLBI and address all Goals and multiple Strategies outlined in the NHLBI
Strategic Plan. These studies will address 1) a need to further illuminate the biological mechanisms and
pathological processes of the contribution of the immune cells, 2) The interaction between the immune
system and the vascular system as a priority research topic and, 3) To advance the Translational Sciences,
we will test the hypothesis in 2K1C mice model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes
-
批准号:10219830
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
-
批准号:10673211
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension
-
批准号:10206263
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes
-
批准号:10650143
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes
-
批准号:10444975
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2020
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8383472
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:7792312
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8013945
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8611809
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
-
批准号:8167897
-
项目类别:
-
资助金额:$16.39万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
Mechanisms of Coronary Arteriolar Dysfunction in Type 2 Diabetes
-
批准号:8197533
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2010
-
负责人:KHALID MATROUGUI
-
依托单位:
MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
-
批准号:7959842
-
项目类别:
-
资助金额:$13.81万
-
财政年份:2009
-
负责人:KHALID MATROUGUI
-
依托单位:
MECHANISMS OF RESISTANCE ARTERY STRUCTURAL REMODELING IN HYPERTENSION
-
批准号:7725311
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2008
-
负责人:KHALID MATROUGUI
-
依托单位:
海外基金